PATENT CLAIM ANALYSIS

Application Number: 15960909
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "183000"]

Abstract:
The use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of rheumatoid pain, especially rheumatoid arthritic pain, very especially preferably chronic rheumatoid arthritic pain.

Claim (Index 2):
A method as claimed in  claim 1 , wherein:\n X is OH, F, OC(O)CH 3  or H; R 1  is CH 3 , C 2 H 5 , C 4 H 9  or t-butyl; R 2  and R 3  are each independently selected from the group consisting of H, CH 3 , C 2 H 5 , i-propyl and t-butyl; or R 2  and R 3  together form a saturated and unsubstituted C 5-6 -cycloalkyl group; and at least four of R 9  to R 13  denote H, and the remainder of R 9  to R 13  are each independently selected from the group consisting of H, Cl, F, OH, CF 2 H, CF 3 , OCH 3  and SCH 3 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.47059
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11294449', '12850208', '10448454', '11003534', '11133190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7866885624280809
- 35 USC 102 Novelty (BERT): 0.5196156127727956
- Combined Prediction Score: 0.7599812674625525
- Mean Citation Score: 281.06451
- Max Citation Score: 312.57202
- Similarity Product: 254.100398067913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test